Novelion Therapeutics Inc.

Two years ago the board of directors of Alexion Pharmaceuticals Inc. began a seismic overhaul of its leadership, strategy and pipeline. The Boston-based rare disease specialist had success with Soli

Just over four years since it was founded, Ireland's Amryt Pharma PLC has completed its acquisition of Aegerion Pharmaceuticals Inc. and hopes to become a sustainable player in the rare diseases s

Amryt Pharma PLC of Ireland agreed to buy Aegerion Pharmaceuticals Inc. , a subsidiary of Canada's Novelion Therapeutics Inc. , on 20 May, giving it full rights to Juxtapid/Lojuxta (lomitapide), th

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Arvelle To Commercialize SK’